文献速递乳房整形与再造美容整形创面修复

乳头保留乳房切除术前先行乳头复位手术的分期乳房再造

Staged breast reconstruction utilizing primary nipple repositioning surgery prior to nipple-sparing mastectomy.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-02-09

该回顾性单中心研究分析了2016至2020年间19例(38侧乳房)因治疗或预防性肿瘤手术目的行乳房固定或缩小成形术后再行分期乳头保留乳房切除术(NSM)的患者,评估两阶段间期及手术、肿瘤、美学和患者报告结局。两阶段平均间隔25周,无乳头乳晕复合体坏死,作者认为若平均等待25周,该术式可安全实施并获得良好美学效果。

要点

  • 19例(38侧乳房)行计划性乳房固定/缩小成形术后分期NSM,两阶段平均间隔25周。
  • NSM后无乳头乳晕复合体坏死,感染和血肿各见于1侧乳房(2.6%),血清肿见于2侧(5.3%)。
  • NSM后皮瓣坏死见于2侧乳房(5.3%),无肿瘤复发,患者报告满意度与幸福感均分分别为63分和67分(满分100)。

核心结论

  • 作者描述其在乳头复位术后行分期NSM的经验,结果提示若术者等待第一与第二阶段之间平均25周,该术式可安全实施并获得美学上有利的结果。

研究设计与样本

  • 经机构审查委员会批准的回顾性研究,回顾单中心2016至2020年所有因治疗或预防性肿瘤手术目的行乳房固定或缩小成形术后分期NSM的患者数据。
  • 共纳入19例患者(38侧乳房),评估两阶段间期以及手术、肿瘤、美学和患者报告结局。

主要发现

  • 两阶段平均间隔25周。
  • NSM后无患者发生乳头乳晕复合体坏死;感染和血肿各见于1侧乳房(2.6%),血清肿见于2侧乳房(5.3%)。
  • 第一阶段乳房固定/缩小成形术后延迟愈合见于8侧乳房(21.1%),NSM后延迟愈合见于12侧乳房(31.6%);NSM后皮瓣坏死见于2侧乳房(5.3%)。
  • 无患者发生肿瘤复发。
  • 患者报告术后满意度与幸福感平均评分分别为63分和67分(满分100)。

临床怎么用

  • 作者描述其分期NSM经验,结果提示术者等待第一与第二阶段之间平均25周时,该术式可安全实施并获得美学上有利的结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Staged nipple-sparing mastectomy (NSM) following mastopexy or breast reduction has become increasingly utilized in patients with large or ptotic breasts. The safety and efficacy of this approach has been demonstrated in recent years. However, the optimal timing between stages has not been established. The authors provide their experience with this staged approach with emphasis on timing between stages. An institutional review board approved this retrospective study. Data of all patients at a single institution who underwent staged NSM following mastopexy or reduction mammaplasty for therapeutic or prophylactic oncologic surgical management from 2016 to 2020 were reviewed. Timing between stages as well as surgical, oncologic, aesthetic, and patient-reported outcomes were evaluated. Nineteen patients (38 breasts) underwent staged NSM following planned mastopexy/breast reduction. The mean time interval between stages was 25 weeks. No patients developed nipple areolar complex necrosis. Infection and hematoma were seen in one breast (2.6%) and seroma in two (5.3%) after NSM. Delayed wound healing was seen in eight breasts (21.1%) after first stage mastopexy/reduction and in 12 breasts (31.6%) after NSM. Skin flap necrosis was noted in two breasts (5.3%) after NSM. No patients developed oncological recurrence. Mean patient-reported post-operative satisfaction and well-being scores were 63 and 67 out of 100, respectively. The authors describe their experience with staged NSM following nipple repositioning procedures. Their results suggest that this procedure can be performed safely with cosmetically favorable results if surgeons wait an average of 25 weeks between first and second stage procedures.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Shih L, Doval A, Burns HR, et al. Staged breast reconstruction utilizing primary nipple repositioning surgery prior to nipple-sparing mastectomy. J Plast Reconstr Aesthet Surg. 2024. PMID: 38428233. doi:10.1016/j.bjps.2024.02.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。